Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Zhang

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Nature Biotechnology|September 10, 2003
Large-scale genotyping of complex DNAGiulia C Kennedy, Hajime Matsuzaki, Shoulian Dong, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full AgonistsXiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
Molecular Therapy. Nucleic Acids|April 15, 2015
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral VectorBryan P Burke, Bernard R Levin, Jane Zhang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic SpirocyclesYingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Cell Metabolism|August 11, 2016
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating NeutrophilsTodd G Kirchgessner, Paul Sleph, Jacek Ostrowski, et al.
Nuclear Medicine and Biology|November 22, 2016
Corrigendum to the inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach [Nucl Med Biol 43 (2016) 215-225]Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nuclear Medicine and Biology|March 1, 2016
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachFrederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nature|November 24, 2006
Global variation in copy number in the human genomeRichard Redon, Shumpei Ishikawa, Karen R Fitch, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Nature Biotechnology|September 10, 2003
Large-scale genotyping of complex DNAGiulia C Kennedy, Hajime Matsuzaki, Shoulian Dong, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full AgonistsXiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
Molecular Therapy. Nucleic Acids|April 15, 2015
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral VectorBryan P Burke, Bernard R Levin, Jane Zhang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic SpirocyclesYingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Cell Metabolism|August 11, 2016
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating NeutrophilsTodd G Kirchgessner, Paul Sleph, Jacek Ostrowski, et al.
Nuclear Medicine and Biology|November 22, 2016
Corrigendum to the inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach [Nucl Med Biol 43 (2016) 215-225]Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nuclear Medicine and Biology|March 1, 2016
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachFrederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nature|November 24, 2006
Global variation in copy number in the human genomeRichard Redon, Shumpei Ishikawa, Karen R Fitch, et al.
Pageof 10